Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
The Motley Fool1d
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
Hosted on MSN40m
What to know about the ruling blocking Trump's order on birthright citizenship
President Donald Trump's executive order denying U.S. citizenship to the children of parents living in the country illegally faced the first of what will be many legal tests on Thursday. It didn't ...
Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...
Jared Goff but better – How Ben Johnson will turn Caleb Williams back into a Heisman Trophy winner
Caleb Williams was supposed to be better than Jayden Daniels. Now it’s Ben Johnson’s turn to turn the No. 1 overall pick of the 2024 NFL Draft into the best young quarterback in the ...
Johnson & Johnson's SWOT analysis: oncology portfolio drives growth amid challenges
Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...
WTTW4h
Johnson Brushes Off Threat of Arrest for Failing to Help Trump’s Mass Deportation Effort
We are not going to be intimidated by those acts of terror to radically shift our way of living,” Mayor Brandon Johnson said. “That’s what individuals who stoke fear into people want to see happen.” ...